Are you over 18 and want to see adult content?
More Annotations
Dé indoorrolschaatsbaan / rollerdisco van Nederland! | Skate Fever
Are you over 18 and want to see adult content?
HTML5 Game Engines - Find Which is Right For You
Are you over 18 and want to see adult content?
ფილმები ქართულად | ფილმები ონლაინში | სერიალები | filmebi qartulad
Are you over 18 and want to see adult content?
Geek Nerdery | Find Your Geek Nerdery
Are you over 18 and want to see adult content?
Comic Book Revolution - Comic Book Reviews Since 2006
Are you over 18 and want to see adult content?
LatinAmericanCupid Reviews 2019 - Truth.Best
Are you over 18 and want to see adult content?
Autokasacja, złomowanie, auto złom, szrot Warszawa | Auto Parts
Are you over 18 and want to see adult content?
Favourite Annotations
National Soft de México - Powered by Kayako Help Desk Software
Are you over 18 and want to see adult content?
A complete backup of adaptivebroadband.org
Are you over 18 and want to see adult content?
Josephine Tran | ACSH 100 E-portfolio
Are you over 18 and want to see adult content?
Only In Your State | Discover What's In Your Own Backyard
Are you over 18 and want to see adult content?
Swami Dayanand Education FoundationSwami Dayanand Charitable Education Foundation
Are you over 18 and want to see adult content?
National Resource Directory | Connecting our Service Members & Veterans
Are you over 18 and want to see adult content?
Text
Members area login
Username
Password
Remember
Forgot login
Click here to register Please enter your email address Please enter your membership ID (optional)Cancel
Follow Cephalalgia
Follow IHS
* Home
& news
* About
the IHS
* Board &
Committees
* Members directory
* ICHD / Guidelines
* Congress
& calendar
* Affiliate societies * Awards, training, newsletters* Learning centre
(website members link)LATEST NEWS
*
Newsflash
<< >>
ICHD-3 now available in Italian The Italian translation is now available on the IHS website12/05/2020
The Italian translation of the International Classification of Headache Disorders, 3rd edition, is now available in the Guidelines section of the IHS website, and can also be accessed below.SEE MORE >>>
VIEW DOCUMENT
> View Document
*
Newsflash
<< >>
Vancouver Declaration II on Global Headache Patient Advocacy 2019 The Vancouver Declaration II, proceedings from the GPAS summit held in September 2019, is now published online in Cephalalgia29/04/2020
In September 2019, the second Global Patient Advocacy Summit (GPAS-II) was convened to revisit issues from the inaugural meeting in September 2017, assess the progress of the International Headache Society Global Patient Advocacy Coalition (IHS-GPAC) in meeting the goals set forth therein, and discuss strategies for achieving established goals and supporting future development. The published Vancouver Declaration II details the outcomes and achievements to date, and strategies goingforward.
SEE MORE >>>
*
Newsflash
<< >>
IHS Fellowship 2020 - application deadline extended You now have until 1 December 2020 to apply for the IHS Fellowship2020
27/04/2020
Due to the Covid-19 pandemic, IHS has decided to move the application deadline for the IHS Fellowship 2020 to 1 December 2020. Details of the award are below and in the Grantssection
SEE MORE >>>
VIEW DOCUMENT
> View Document
*
Important update
<< >>
2018 IHS Fellowship reports The 2018 Fellows have now completed their research - read theirreports
31/03/2020
The 2018 IHS Fellowship recipients have now completed their research and their reports are available below. Application is open for the 2020 Fellowship - apply today if interested - application deadline 1 July 2020.SEE MORE >>>
VIEW DOCUMENT
VIEW DOCUMENT
> View Document > ViewDocument
*
Newsflash
<< >>
IHS Newsletter no. 25 now available Read the latest news from IHS30/03/2020
Issue no. 25 of the IHS Newsletter, our in-house online publication to update you on recent IHS and related society activities, is nowpublished.
This issue includes updates from the IHS President and Secretary, review of significant articles on headache published in 2019, ICOP editorial and reports from IHS educational activities and grant and fellowship recipients. Download issue 25 below.SEE MORE >>>
VIEW DOCUMENT
> View Document
*
Newsflash
<< >>
Guidelines for episodic migraine in adults - member review - deadlineap...
IHS members - have your input into the episodic migraine guidelines26/03/2020
The Clinical Trials Guidelines Committee has been working on updating the 'Guidelines for Controlled Trials of Preventive Treatment of Migraine Attacks in Episodic Migraine in Adults'. The document is now available for member review and members should have received a mailshot with the document. If you have not received this and wish to access the document please contact IHS. Deadline for comments: 1 April 2020SEE MORE >>>
*
Newsflash
<< >>
Cluster Headache Awareness Day - 21 March Join the campaign to highlight this debilitating condition19/03/2020
IHS is running a global campaign for the awareness of Cluster Headache and we will focus on the diagnosis, treatments and cause of this debilitating condition. Click to read in Spanish--
Portuguese
--
Mandarin
We hope this advocacy campaign brings together the global community to disseminate cluster headache diagnosis and prevention strategies to clinicians, researchers and patients in the hope of achieving better patient outcomes and contributing to the IHS mission statement of working toward headache relief worldwide. We invite you to participate in this campaign and share the facts about Cluster Headache through our social media accounts. To join the conversation, use #ClusterHeadacheDay2020 and #ClusterDay20 on Twitterand LinkedIn
. Use
our Media Kit including logos, to elevate the conversation of Cluster Headache awareness and help spread the word about this important advocacy campaign. As headache professionals, it is our duty to communicate diagnostic and preventive methods to our colleagues, patients and the general public in order to ensure proper care at the proper time and hopefully avoid or, at the very least, lessen the impact it has on daily functioning and quality of life. Throughout this year, IHS will be offering a variety of materials dedicated to communicating diagnostic and treatment methods geared toward clinicians, researchers and those living with Cluster Headache. We plan an exciting lineup of fact sheets, webinars and other communications to share with you, and we encourage you to share theinformation widely.
Together, we can provide the latest research, clinical practices, treatments and self-management techniques to work toward a world with better understanding of Cluster Headache.SEE MORE >>>
VIEW DOCUMENT
> View Document
*
Newsflash
<< >>
Application for IHS Fellowship now open Apply today for the IHS Fellowship - Basic or Clinical scienceheadache research
05/03/2020
The IHS fellowship award aims to support innovative and impactful research from young investigators, promote the career of young investigators in the field of headache, and increase the knowledge base of headache disorders. Applications for basic or clinical science headache research, or a combination of basic and clinical research,will be considered.
Eligibility: Within 6 years from completing training (MD, PhD, specialty training, whatever was last) not including non-professionalperiods
Award value: £ 50,000 Please see below for more information and an application form. DEADLINE FOR APPLICATIONS: 1 JULY 2020SEE MORE >>>
VIEW DOCUMENT
> View Document
*
Newsflash
<< >>
Apply for the Master in Headache Disorders Apply today to learn about all different headache disorders and gainan academic degree
25/02/2020
Application is now open for the 3rd Master in Headache Disorders (MHD) at the University of Copenhagen. This is a 2-year part time program on all headache disorders following which you will receive an AcademicMaster Degree.
In MHD1 from 2016-2018 17 Masters graduated with excellence and at present 23 MHD2 students will graduate in June 2020. They come from 17 different countries from The Philippines, Pakistan, Iran, Europe and USA. The students background qualifications in MHD2 are a great interest and experience in clinical management of pain and headache. The group consists of 16 neurologists, 1 GP, 4 nurses, 1 physiotherapist and 1 osteopath. In a world with limited resources education is the key, especially within the headache field, where there is a significant unmet need foracademic education.
For more information please click HERESEE MORE >>>
*
Newsflash
<< >>
IHS Research Grants awarded IHS is pleased to announce the successful applications for the 2019Research Grants
14/02/2020
For the first time in 2019 the IHS Board opened applications for research grants for scientific projects. Two projects were selected from over 30 applications received, each receiving € 75,000: The successful applications were: Menstrual migraine: estrogen influences migraine susceptibility by affecting the balance of oxytocin and CGRP signaling. Principle investigator: Kristian A Haanes. Co-investigators: Lars Edvinsson (Lund, Sweden), Diana Krause (Irvine, USA). Research location: Glostrup Research Park, Copenhagen University Hospital, Copenhagen,Denmark
BIOMIGRAINE: A multidisciplinary approach to the identification of BIOmarkers of MIGRAINE: a proof of concept study based on the stratification of responders to CGRP monoclonal antibodies. Principle investigator: Patricia Pozo Rosich. Co-investigators: Marta Torres-Ferrus (Barcelona, Spain), Cristina Tassorelli and Roberto de Icco (Pavia, Italy), Arne May and Christian Ziegeler (Hamburg, Germany). Research location: Headache Clinical Unit & Research Group, Vall d’Hebron Institute of Research, Barcelona, Spain A short overview of both these projects can be found below. Congratulations to the winning applicants!SEE MORE >>>
VIEW DOCUMENT
VIEW DOCUMENT
> View Document
> View Document
*
Newsflash
<< >>
International Classification of Orofacial Pain (ICOP) published Read the 1st ICOP in Cephalalgia31/01/2020
The first edition of the International Classification of Orofacial Pain (ICOP) is published in Cephalalgia. This publication was written by a collaborative group consisting of members of the Orofacial and Head Pain Special Interest Group (OFHP SIG) of the International Association for the Study of Pain (IASP), the International Network for Orofacial Pain and Related Disorders Methodology (INfORM), and the American Academy of Orofacial Pain(AAOP).
SEE MORE >>>
VIEW DOCUMENT
> View Document
*
Important update
<< >>
Visiting Professors in Kyrgyzstan and Iran Continuing its education outreach, IHS funded Visiting Professors to present at meetings in Kyrgyzstan and Iran14/01/2020
Continuing its education outreach, IHS funded Visiting Professors to present at meetings in Kyrgyzstan and Iran in autumn 2019. Visiting Professors is an IHS education initiative which has been running since 2012 with the aim to send headache specialists as representatives of IHS to attend regional meetings, or teach at a headache centre, in countries that might need or want increased headache education and motivation and where, without financial support, attendance of an international specialist would not bepossible.
The local organisers of the meetings report.SEE MORE >>>
VIEW DOCUMENT
VIEW DOCUMENT
> View Document
> View Document
HOME & NEWS
Welcome to the website for the International Headache Society The International Headache Society (IHS) is the world's leading membership organisation for those with a professional commitment to helping people affected by headache. As a charity, the purpose of IHS is to advance headache science, education, and management, and promote headache awareness worldwide. This site promotes the Society and its activities, and is the home of the Society's international journal Cephalalgia. We welcome Society members and all who work or seek information in the field of headache.MESSOUD ASHINA
President, International Headache SocietyRead in Portuguese
--
Spanish -- Mandarin
Only $140 for online membership IHS IN 2019 - HONORARY SECRETARY'S REPORT 2019 was another very busy year for IHS with many activities and key publications, and the most successful International Headache Congress for many years. The most important activities are listed below. Any comments are welcome (see my email address at the end of this report).IHC 2019, DUBLIN
The 19th International Headache Congress (IHC) held in Dublin in September proved to be our most successful congress for many years. Over 2,000 delegates attended, the highest number since 2003, and enjoyed an incredibly diverse and rich programme covering all topics of headache medicine through teaching courses, plenary sessions, 'one topic, two views' sessions, lunchtime and parallel sessions, and satellite symposia. Oral presentations from submitted abstracts highlighted the recent exciting developments in headache medicine and over 500 posters were displayed, the best of which were selected for presentation as e-posters. The IHS Juniors Group was also active throughout the congress, the highlight of which was the Headache Science Excellence Tournament, an event which has become a true IHC tradition. Six presenters were selected in a blinded fashion based on the content of their submitted abstract and two winners were selected by the audience: one for a clinical research presentation and one for basic research. The presentation award winners were Mohammad Al-Mahdi Al-Karagholi from Copenhagen, Denmark (Clinical science) and Zach Bertels from the University of Illinois at Chicago, USA (Basic science). The Juniors group also facilitated the attendance of over 40 young clinicians and researchers from all over the world, especially from developing countries, through travel grants and held networking events during the congress. IHS SPECIAL RECOGNITION AWARD The 2019 Special Recognition Award was given to Fumihiko Sakai during the IHC Opening Ceremony in Dublin. Professor Sakai was President of IHS from 2005 to 2007 and Congress Chair of the 12th IHC held in Kyoto, Japan, in 2005. He founded and was Chair of the Asian Regional Consortium for Headache from 2009 until 2016, and organised the first IHS Headache Master School in Asia in Japan in 2013. Subsequent Asian Master Schools have proved very successful and educated young researchers and physicians from all over the Asian region. Professor Sakai led the epidemiology and impact study on employees with migraine within Fujitsu Japan, Korea, and Philippines, which was endorsed by IHS and the World Health Organization–Asia-Pacific Region. The results of this study and his participation in the IHS Global Patient Advocacy Coalition (IHS-GPAC) led to him approaching Fujitsu regarding an employee headache care programme, led by IHS-GPAC in conjunction with the Japanese Headache Society and the Japan Patient AdvocacyCoalition.
GUIDELINES
The Clinical Trials Committee has published two sets of guidelines: 'Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition' and 'Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine in children and adolescents, 1st edition'. Junior members of the Committee also published 'Adherence to the 2008 IHS guidelines for controlled trials of drugs for the preventive treatment of chronic migraine inadults’.
Future guidelines to be published include a revision of preventive treatment of episodic migraine (expected publication summer 2020), controlled trials on neuromodulation in migraine, controlled trials for idiopathic intracranial hypertension, and a revision of acute and preventive treatment of cluster headache. Additionally Arne May has worked closely with a collaborative group consisting of members of the Orofacial and Head Pain Special Interest Group (OFHP SIG) of the International Association for the Study of Pain (IASP), the International Network for Orofacial Pain and Related Disorders Methodology (INfORM), and the American Academy of Orofacial Pain (AAOP) to develop the International Classification of Orofacial Pain (ICOP). This was published in Cephalalgia in February 2020. The ICHD-3 has now been translated into Brazilian Portuguese, Bulgarian, Chinese, Chinese (Mandarin), French, German, Japanese, Korean, Portuguese, Romanian and Spanish. All IHS published guidelines and ICHD translations are freely available on the IHS and Cephalalgia websites. CEPHALALGIA AND CEPHALALGIA REPORTS IHS was delighted to see the Cephalalgia impact factor for 2018 rise to 4.438 (2017: 3.882). Cephalalgia is now ranked 35 out of 199 in Clinical Neurology and 64 out of 257 in Neuroscience journals. Cephalalgia Reports, the open-access silhouette title to Cephalalgia providing an international forum for original research papers, review articles, clinical perspectives, case reports, technical reports and short communications, was launched in 2018 and now has 47 published articles. The publisher is currently applying for PubMed entry so the journal can start collecting citations. Please consider publishing your research or views in Cephalalgia Reports. The journal actively encourages high quality papers in emerging observations with translational potential not yet realised, reports limited to regional relevance which may validate and add to existing studies, RCTs with negative outcomes, confirmatory studies, technical reports, articles with a more clinical emphasis, pilot trials which may stimulate therapeutic innovation and scientifically rigorous pathophysiological and pharmacological studies. Please visit the Cephalalgia Reports website if you would like to submit your work to this exciting new publication. IHS GLOBAL PATIENT ADVOCACY SUMMIT / GLOBAL PATIENT ADVOCACY COALITION Following the hugely successful 1st Global Patient Advocacy Symposium (GPAS) held in Vancouver, Canada, in September 2017, which brought together patients, patient advocates, patient advocacy organisations, healthcare professionals, the world's leading professional neurology, headache, and pain societies, the World Health Organization, pharmaceutical manufacturers, scientists, and regulatory agencies to advance issues of importance to patients affected by headache worldwide, and subsequent publication of the Vancouver Declaration on Global Headache Patient Advocacy published in Cephalalgia, a Global Patient Advocacy Coalition (IHS-GPAC) was formed and a second GPAS held in Dublin prior to the IHC. The mission of IHS-GPAC is to help implement optimal standards of care for those affected by migraine and other headache disorders and raise awareness of their impact on individuals and society. Its current activities are focused on engaging and partnering with global employers to raise awareness of and reduce the stigma surrounding migraine and other headache disorders, while providing education, resources and workplace initiatives for employers and employees that will provide care for those in need and improve quality of life for those impacted. Ultimately the resources and key learnings from these initiatives will be used to engage local advocates in regions around the world to implement similar workplace programmes with localemployers.
The proceedings from GPAS II will be published as the Dublin Declaration in 2020. GRANTS AND FELLOWSHIPS IHS was pleased to continue to award grants and fellowships to juniorcolleagues in 2019.
IHS Fellowship
Inge Loonen, Netherlands. Research title: The link between migraine aura and cerebrovascular endothelial dysfunction. Institution: Harvard Medical School-Massachusetts General Hospital – mentor: Cenk Ayata Connar Westgate, UK. Research title: The search for disease mechanisms and new drug targets in idiopathic intracranial hypertension. Institution: Danish Headache Center – mentor: Sajedeh Eftekhari IHS-American Brain Foundation/American Academy of Neurology Clinical Research Training Scholarship in Headache Faisal Amin, Denmark. Research title: Streamlining clinical management and neuroimaging for precision diagnosis of post-traumatic headache IHS Headache Trainee Programme Khatia Gvantseladze, Georgia. Institution: Danish Headache Center – mentor: Messoud Ashina IHS Short-Stay Scholarships Gunjan Kumar, India. Institution: Tallaght Hospital, Dublin –mentor: Sean O'Dowd
Agaath Hedina Manickam, India. Institution: Beaumont Hospital, Dublin – mentor: Martin Ruttledge Ana Podgorac, Serbia. Institution: Mater Hospital, Dublin – mentor:Roisin Lonergan
IHS RESEARCH GRANTS
For the first time the IHS Board opened applications for research grants for scientific projects. Two projects were selected from over 30 applications received, each receiving € 75,000: Menstrual migraine: estrogen influences migraine susceptibility by affecting the balance of oxytocin and CGRP signaling. Principle investigator: Kristian A Haanes. Co-investigators: Lars Edvinsson (Lund, Sweden), Diana Krause (Irvine, USA). Research location: Glostrup Research Park, Copenhagen University Hospital, Copenhagen,Denmark
BIOMIGRAINE: A multidisciplinary approach to the identification of BIOmarkers of MIGRAINE: a proof of concept study based on the stratification of responders to CGRP monoclonal antibodies. Principle investigator: Patricia Pozo Rosich. Co-investigators: Marta Torres-Ferrus (Barcelona, Spain), Cristina Tassorelli and Roberto de Icco (Pavia, Italy), Arne May and Christian Ziegeler (Hamburg, Germany). Research location: Headache Clinical Unit & Research Group, Vall d’Hebron Institute of Research, Barcelona, Spain EDUCATIONAL ACTIVITIES The 6th European International Headache Academy (iHEAD) was held in Dublin in September, immediately prior to the IHC. This year the academy was opened up to invite participants from all over the world and 110 delegates representing 31 countries attended. An IHS Headache Master School was held in Colombia in October 2019, organised by the Colombian Neurology Society in collaboration with the IHS Education Committee. Over 100 delegates attended from Colombia, Argentina, Peru, Mexico, Chile and Bolivia. Visiting Professors were sent to teach in Nepal, Iran, Philippines andKyrgyz Republic.
WORLD BRAIN DAY DEDICATED TO MIGRAINE – 22 JULY 2019 The World Federation of Neurology (WFN) World Brain Day 2019 was dedicated to migraine. Many events took place worldwide including a webinar on 22 July with a panel of esteemed specialists and advocates including David Dodick (IHS), William Carroll, Wolfgang Grisold and Tissa Wijeratne (WFN), Audrey Craven (Migraine Association of Ireland), and Elaine Jones (American Academy of Neurology). This can be viewed on the World Brain Day website. Headache societies and patient organisations around the world were involved with various activities and #worldbrainday trended on social media platforms.GOVERNANCE
In September 2019 a new Board was elected. Messoud Ashina succeeded Lars Edvinsson as President, Cristina Tassorelli joined as President-elect, and the three elected Trustees, Fayyaz Ahmed, Gianluca Coppola and Alexandra Sinclair, took up office. The Board has also appointed four co-opted members to ensure global representation: Mi Ji Lee (South Korea), Marco Lisicki (Argentina), Aynur Özge (Turkey) and Kirill Skorobogatykh (Russia). There were also new Committee Chair appointments as terms ended: Peter Goadsby was appointed as Chair of the Classification Committee to succeed Jes Olesen who has served for over 30 years and overseen publication of all three versions of the International Classification of Headache Disorders (ICHD); following her election as President-elect, Cristina Tassorelli has stepped down as Chair of the Clinical Trials Committee and Gisela Terwindt was appointed as the new Chair; the Board agreed to appoint a Co-Chair for the Education Committee and Henrik Winther Schytz was appointed – he will serve with Allan Purdy for 2 years, after which Allan will retire; Anne Ducros has succeeded Luiz Paolo de Queiroz as Chair of the MembershipCommittee.
The Primary Care Special Interest Group was disbanded.MEMBERSHIP
In 2019 we had the largest ever number of members – it is hoped IHS can sustain this high level of membership members in future years.THANKS
All these activities and achievements would have been impossible without the help of Board members, Committee Chairs, and other IHS members who do a great deal of voluntary work to ensure these activities are professionally executed, and without whom the society could not function. On behalf of the society I extend my thanks to them, and to the IHS administration and finance teams, and thecongress organiser.
More detail on the activities highlighted above can be found in the Newsletters on the IHS website. IHS welcomes comments or proposals for IHS activities – please email me with any suggestions you may have.Stefan Evers
University of Münster and Krankenhaus Lindenbrunn, Münster, Germany Email: everss@uni-muenster.de To read the Presidential letter, September 2019, please click HERE IHS Links IHS Partners IHS Sponsors Contact theIHS
International Headache Society, 4th Floor, Mitre House, 44-46 Fleet Street, London, EC4Y 1BN. United Kingdom. The International Headache Society is a registered charity: Registered Charity Number: 1042574 2013 International Headache Society You need to be a member of the IHS to access this area of the website, please sign in to continue. To find out more about membership types and how to join the IHS click onto the 'join' banner on the home page. Close this box to continue. Access to the Members Directory is restricted to Standard IHS membersMEMBERS LOGIN
Your membership is currently shown as unpaid. To renew your membership online click HERE . Otherwise, please contact Carol Taylor to discuss your renewal. This document is only available to members – please login.Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0